ArticleBreast cancer research : BCR2007

Heregulin beta1 drives gefitinib-resistant growth and invasion in tamoxifen-resistant MCF-7 breast cancer cells.

Iain R Hutcheson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.